1. Home
  2. EXC vs KVUE Comparison

EXC vs KVUE Comparison

Compare EXC & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXC
  • KVUE
  • Stock Information
  • Founded
  • EXC 1999
  • KVUE 2022
  • Country
  • EXC United States
  • KVUE United States
  • Employees
  • EXC N/A
  • KVUE N/A
  • Industry
  • EXC Power Generation
  • KVUE Specialty Chemicals
  • Sector
  • EXC Utilities
  • KVUE Consumer Discretionary
  • Exchange
  • EXC Nasdaq
  • KVUE Nasdaq
  • Market Cap
  • EXC 45.5B
  • KVUE 39.9B
  • IPO Year
  • EXC N/A
  • KVUE 2023
  • Fundamental
  • Price
  • EXC $42.73
  • KVUE $18.13
  • Analyst Decision
  • EXC Buy
  • KVUE Buy
  • Analyst Count
  • EXC 12
  • KVUE 12
  • Target Price
  • EXC $46.75
  • KVUE $24.04
  • AVG Volume (30 Days)
  • EXC 5.1M
  • KVUE 24.9M
  • Earning Date
  • EXC 10-29-2025
  • KVUE 11-06-2025
  • Dividend Yield
  • EXC 3.73%
  • KVUE 4.52%
  • EPS Growth
  • EXC 8.94
  • KVUE 28.77
  • EPS
  • EXC 2.64
  • KVUE 0.74
  • Revenue
  • EXC $23,766,000,000.00
  • KVUE $15,141,000,000.00
  • Revenue This Year
  • EXC $5.45
  • KVUE N/A
  • Revenue Next Year
  • EXC $2.90
  • KVUE $3.13
  • P/E Ratio
  • EXC $16.28
  • KVUE $24.50
  • Revenue Growth
  • EXC 4.47
  • KVUE N/A
  • 52 Week Low
  • EXC $35.94
  • KVUE $17.15
  • 52 Week High
  • EXC $48.11
  • KVUE $25.17
  • Technical
  • Relative Strength Index (RSI)
  • EXC 35.97
  • KVUE 29.68
  • Support Level
  • EXC $42.75
  • KVUE $18.05
  • Resistance Level
  • EXC $43.67
  • KVUE $19.42
  • Average True Range (ATR)
  • EXC 0.58
  • KVUE 0.76
  • MACD
  • EXC -0.08
  • KVUE -0.17
  • Stochastic Oscillator
  • EXC 1.38
  • KVUE 25.89

About EXC Exelon Corporation

Exelon serves approximately 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D.C.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.

Share on Social Networks: